Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1967 1
1970 2
1971 1
1972 1
1974 3
1975 1
1976 4
1977 3
1979 3
1980 4
1982 3
1983 1
1984 3
1985 4
1986 5
1987 4
1989 7
1990 3
1991 1
1992 3
1993 11
1994 6
1995 2
1996 6
1997 5
1998 3
1999 8
2000 1
2001 2
2002 3
2003 3
2004 1
2005 9
2006 6
2007 1
2008 5
2009 5
2010 1
2011 9
2012 13
2013 13
2014 11
2015 12
2016 19
2017 15
2018 24
2019 53
2020 50
2021 33
2022 34
2023 35
2024 21
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Results by year

Filters applied: . Clear all
Page 1
Management of chronic urticaria in children: a clinical guideline.
Caffarelli C, Paravati F, El Hachem M, Duse M, Bergamini M, Simeone G, Barbagallo M, Bernardini R, Bottau P, Bugliaro F, Caimmi S, Chiera F, Crisafulli G, De Ranieri C, Di Mauro D, Diociaiuti A, Franceschini F, Gola M, Licari A, Liotti L, Mastrorilli C, Minasi D, Mori F, Neri I, Pantaleo A, Saretta F, Tesi CF, Corsello G, Marseglia GL, Villani A, Cardinale F. Caffarelli C, et al. Among authors: gola m. Ital J Pediatr. 2019 Aug 15;45(1):101. doi: 10.1186/s13052-019-0695-x. Ital J Pediatr. 2019. PMID: 31416456 Free PMC article.
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Gargiulo L, Ferrucci SM, Ibba L, Ingurgio RC, Alfano A, Amoruso GF, Balato A, Barbagallo T, Barei F, Bellinato F, Brianti P, Burroni AG, Campanati A, Caroppo F, Carugno A, Bello GD, De Franco F, Fortina AB, Foti C, Gaiani FM, Girolomoni G, Gola M, Guanti MB, Gurioli C, Legori A, Loconsole F, Magnaterra E, Malagoli P, Margiotta FM, Marzano AV, Mercuri SR, Milanesi N, Musumeci ML, Napolitano M, Ortoncelli M, Paolino G, Patruno C, Pella P, Pezzolo E, Prestinari F, Recalcati S, Ribero S, Rongioletti F, Rossi M, Satolli F, Savoia P, Sciarrone C, Spigariolo C, Stabile G, Tirone B, Tolino E, Zerbinati N, Potenza C, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: gola m. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e807-e811. doi: 10.1111/jdv.20699. Epub 2025 Apr 17. J Eur Acad Dermatol Venereol. 2025. PMID: 40247595 No abstract available.
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Barei F, Macchi S, Calzari P, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, Ippoliti E, Gurioli C, Piraccini BM, Trave I, Cozzani E, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Campanati A, Gioacchini H, Pisapia A, Avallone G, Micali G, Musumeci ML, Ortega R, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Patruno C, Esposito M, Fargnoli MC, De Berardinis A, Ferreli C, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Lauletta G, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: gola m. Clin Exp Dermatol. 2025 Oct 27;50(11):2221-2231. doi: 10.1093/ced/llaf275. Clin Exp Dermatol. 2025. PMID: 40578600
Severe Adult Atopic Dermatitis: Clinical Challenges.
Russo F, Flori ML, Gola M, Milanesi N. Russo F, et al. Among authors: gola m. Dermatitis. 2020 Jul/Aug;31(4):e48-e49. doi: 10.1097/DER.0000000000000592. Dermatitis. 2020. PMID: 32209869 No abstract available.
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, Barei F, Burroni AG, Caccavale S, Calzavara-Pinton P, Esposito M, Fargnoli MC, Ferrucci SM, Foti C, Girolomoni G, Gola M, Guanti MB, Gurioli C, Magliulo M, Maurelli M, Morrone P, Musumeci ML, Napolitano M, Ortoncelli M, Patruno C, Piraccini BM, Pezzolo E, Ribero S, Rossi M, Savoia P, Sciarrone C, Tirone B, Vaccino M, Veronese F, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: gola m. J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10. J Dermatolog Treat. 2024. PMID: 39389612 Free article.
Letter: Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Lauletta G, Potestio L, Patruno C, Ferrucci SM, Angileri L, Barei F, Ortoncelli M, Ribero S, Girolomoni G, Malagoli P, Pezzolo E, Narcisi A, Gargiulo L, Guanti MB, Musumeci ML, Ortega R, Gurioli C, Campanati A, Caroppo F, Legori A, Rossi M, Tolino E, D'Erme AM, Milanesi N, Sciarrone C, Gola M, Magnaterra E, Grieco T, Satolli F, Loconsole F, Brianti P, Stingeni L, Hansel K, Bertoldi AM, Napolitano M. Lauletta G, et al. Among authors: gola m. Dermatitis. 2025 Jun 5. doi: 10.1089/derm.2025.0129. Online ahead of print. Dermatitis. 2025. PMID: 40470535 No abstract available.
Interventions for atrophic rhinitis.
Mishra A, Kawatra R, Gola M. Mishra A, et al. Among authors: gola m. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008280. doi: 10.1002/14651858.CD008280.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336840 Free PMC article.
Catgut dermatitis.
Gola M, Francalanci S, Campolmi P, Sertoli A. Gola M, et al. Contact Dermatitis. 1986 Aug;15(2):104-5. doi: 10.1111/j.1600-0536.1986.tb01297.x. Contact Dermatitis. 1986. PMID: 3780200 No abstract available.
Motives for pornography use and women's sexual wellbeing: Insights from a 42-country study.
Gewirtz-Meydan A, Feder H, Nagy L, Koós M, Kraus SW, Demetrovics Z, Potenza MN, Ballester-Arnal R, Batthyány D, Bergeron S, Billieux J, Briken P, Burkauskas J, Cárdenas-López G, Carvalho J, Castro-Calvo J, Chen L, Ciocca G, Corazza O, Csako RI, Fernandez DP, Fernandez EF, Fujiwara H, Fuss J, Gabrhelík R, Gjoneska B, Gola M, Grubbs JB, Hashim HT, Islam MS, Ismail M, Jiménez-Martínez MC, Jurin T, Kalina O, Klein V, Költő A, Lee CT, Lee SK, Lewczuk K, Lin CY, Lochner C, López-Alvarado S, Lukavská K, Mayta-Tristán P, Miller DJ, Orosová O, Orosz G; Sungkyunkwan University’s research team; Ponce FP, Quintana GR, Quintero Garzola GC, Ramos-Diaz J, Rigaud K, Rousseau A, De Tubino Scanavino M, Schulmeyer MK, Sharan P, Shibata M, Shoib S, Sigre-Leirós V, Sniewski L, Spasovski O, Steibliene V, Stein DJ, Strizek J, Štulhofer A, Ünsal BC, Vaillancourt-Morel MP, Van Hout MC, Bőthe B. Gewirtz-Meydan A, et al. Among authors: gola m. J Behav Addict. 2025 Feb 12;14(1):114-130. doi: 10.1556/2006.2024.00040. Print 2025 Mar 28. J Behav Addict. 2025. PMID: 39945771 Free PMC article.
463 results